基于心脏亚结构三维剂量分布验证并改良乳腺癌放疗患者急性心脏事件预测模型
该队列研究纳入910例保乳术后接受放疗的乳腺癌女性患者,中位随访7.6年,30例发生急性心脏事件。急性心脏事件累积发生率每增加1 Gy升高16.5%(95% CI 0.6至35.0;P=0.042)。左心室接受5 Gy体积(LV-V5)似为比平均心脏剂量更好的预测因素,含LV-V5、年龄和加权急性心脏事件风险评分的模型c-statistic为0.83(95% CI 0.75至0.91)。
要点
- 910例乳腺癌保乳术后放疗患者中位随访7.6年,30例发生急性心脏事件。
- 急性心脏事件累积发生率每Gy增加16.5%(95% CI 0.6至35.0;P=0.042)。
- LV-V5、年龄和加权风险评分模型的c-statistic为0.83(95% CI 0.75至0.91)。
核心结论
- 放疗后9年内急性心脏事件存在显著剂量效应关系。
- 使用平均心脏剂量时,每Gy相对增加与既往研究报告相似。
- LV-V5似乎比平均心脏剂量更好地预测急性心脏事件。
- 本研究证实减少心脏辐射暴露以避免乳腺癌放疗后急性心脏事件超额风险的重要性。
研究设计与样本
- 队列研究,纳入910例连续女性乳腺癌患者,均为保乳术后接受放疗。
- 主要终点为随访9年内急性心脏事件累积发生率。
- 从三维计算机断层扫描计划数据收集平均心脏剂量及心脏亚结构多种剂量分布参数。
主要发现
- 中位平均心脏剂量为2.37 Gy(范围0.51至15.25 Gy)。
- 中位随访时间7.6年(范围0.1至10.1年),期间30例患者发生急性心脏事件。
- 急性心脏事件累积发生率每Gy增加16.5%(95% CI 0.6至35.0;P=0.042)。
- 左心室接受5 Gy体积(LV-V5)是最重要的预后剂量-体积参数。
- 急性心脏事件最优多变量正常组织并发症概率模型含LV-V5、年龄和每例患者加权急性心脏事件风险评分,c-statistic为0.83(95% CI 0.75至0.91)。
关键数值与推荐
- 急性心脏事件累积发生率每Gy增加16.5%(95% CI 0.6至35.0;P=0.042)。
- 最优多变量正常组织并发症概率模型c-statistic为0.83(95% CI 0.75至0.91)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose A relationship between mean heart dose (MHD) and acute coronary event (ACE) rate was reported in a study of patients with breast cancer (BC). The main objective of our cohort study was to validate this relationship and investigate if other dose-distribution parameters are better predictors for ACEs than MHD. Patients and Methods The cohort consisted of 910 consecutive female patients with BC treated with radiotherapy (RT) after breast-conserving surgery. The primary end point was cumulative incidence of ACEs within 9 years of follow-up. Both MHD and various dose-distribution parameters of the cardiac substructures were collected from three-dimensional computed tomography planning data. Results The median MHD was 2.37 Gy (range, 0.51 to 15.25 Gy). The median follow-up time was 7.6 years (range, 0.1 to 10.1 years), during which 30 patients experienced an ACE. The cumulative incidence of ACE increased by 16.5% per Gy (95% CI, 0.6 to 35.0; P = .042). Analysis showed that the volume of the left ventricle receiving 5 Gy (LV-V5) was the most important prognostic dose-volume parameter. The most optimal multivariable normal tissue complication probability model for ACEs consisted of LV-V5, age, and weighted ACE risk score per patient (c-statistic, 0.83; 95% CI, 0.75 to 0.91). Conclusion A significant dose-effect relationship was found for ACEs within 9 years after RT. Using MHD, the relative increase per Gy was similar to that reported in the previous study. In addition, LV-V5 seemed to be a better predictor for ACEs than MHD. This study confirms the importance of reducing exposure of the heart to radiation to avoid excess risk of ACEs after radiotherapy for BC.
引用
- van den Bogaard VA, Ta BD, van der Schaaf A, et al. Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures. J Clin Oncol. 2017. PMID: 28095159. doi:10.1200/JCO.2016.69.8480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。